Orthocell Limited – Trademark Portfolio
Entity Type: 99
Orthocell Limited holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 12 trademarks are registered and 3 are pending. Notable registered marks include MATT, SMRT, REMPLIR, STRIATE+, and ORTHO-ATI.
Building 191,
Murdoch University South St MURDOCH W
Showing of trademarks Trademarks
Trademark Classifications
Orthocell Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Orthocell Limited have?
Orthocell Limited has 16 U.S. trademarks filed with the USPTO. Of these, 12 registered, 3 pending, 1 abandoned.
What trademark classes does Orthocell Limited file in?
Orthocell Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Orthocell Limited's most well-known trademarks?
Orthocell Limited's registered trademark portfolio includes well-known marks such as MATT, SMRT, REMPLIR, STRIATE+, and ORTHO-ATI. These are among 12 currently registered trademarks in the portfolio.
What is Orthocell Limited's trademark registration success rate?
Orthocell Limited has a 92% trademark registration rate, with 12 out of 13 resolved applications resulting in successful registration. Currently, 3 applications are pending review.